Cherry Hill Sales Recalls Medicated Anti-Itch Cream Due to CGMP Deviations
Cherry Hill Sales Co. is voluntarily recalling 4,800 cartons of MakeSense PHARMA Medicated Anti-Itch Cream due to Current Good Manufacturing Practice (CGMP) deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that may cause temporary or medically reversible adverse health consequences. The source cites CGMP deviations without reporting specific illnesses or injuries, fitting the Moderate severity criteria for voluntary precautionary recalls.
Plain-English summary
Cherry Hill Sales Co. is voluntarily recalling 4,800 cartons of MakeSense PHARMA Medicated Anti-Itch Cream with Soothing Aloe Vera and Vitamin E. The product is a 1-ounce (28 g) tube containing 1% Camphor and 1% Menthol, manufactured in China and distributed by Cherry Hill Associates in Chesapeake, Virginia. The recall was initiated on January 27, 2017, and was classified as Class II by the FDA.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The affected product is identified by Lot 103814, with an expiration date of 08/17, NDC 69020-201-28, and UPC 85718005016. The recall status is currently terminated, with a termination date of April 19, 2017.
The product was distributed in Michigan, Illinois, New York, Florida, and Pennsylvania. Consumers should check their inventory for the specific lot number and expiration date listed above. If they possess the affected product, they should stop using it and contact the recalling firm for instructions on disposal or return.
The recalled product
- Product
- MakeSense PHARMA Medicated ANTI-ITCH CREAM WITH SOOTHING ALOE VERA AND VITAMIN E, Camphor-1% Menthol-1%, 1oz.(28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-201-28
- Manufacturer
- Cherry Hill Sales Co.
- Category
- Drug — Topical Medication
- Hazard
- Affected units
- 4,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 103814
- Exp. 08/17 NDC 69020-201-28 UPC 85718005016
Distribution
Part of a larger recall action
This product is one of 5 recalled by Cherry Hill Sales Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Cherry Hill Sales Co.
See all →- ModerateCherry Hill Sales Recalls MakeSense Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Hemorrhoidal Cream Due to Manufacturing Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Clotrimazole Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls MakeSense First Aid Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
Same hazard · cgmp deviations
See all →- SevereBaxter Recalls Famotidine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Nexterone Amiodarone Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Pantoprazole Sodium Infusion Bags Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateCVS Health Natural Sleep Aid Chewable Tablets Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-09
- HighChina-Gel Topical Pain Reliever Recall Due to Manufacturing Contamination
FDA (Drugs) · 2021-09-08
- ModerateUS Pharmaceuticals Recalls CVS Therapeutic Menthol Gel Due to Water Quality Issues
FDA (Drugs) · 2019-08-21
- ModeratePromethazine HCl Topical Ointment Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-02
- ModerateCaring Mill cherry cough drops recalled after facility inspection findings
FDA (Drugs) · 2026-04-22
- ModerateValeant Recalls Cortaid 12-Hour Anti-itch Cream Due to cGMP Deviations
FDA (Drugs) · 2018-10-31